GlassScriptPhysician profile
Alberto Chavez Velazquez
NPI 1679865414
$6,040.24
in general payments reported to CMS, 2019-2025
17 companies · $1,849 in 2025
The $1,849 reported for 2025 was more than what 75% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,136 · 2020: $16.71 · 2021: $125 · 2022: $350 · 2023: $211 · 2024: $353 · 2025: $1,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605 · Travel and Lodging: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.53 |
| Travel and Lodging | $808.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $2,695.90 | 2019-2022 | |
| Medtronic, INC. | $1,139.95 | 2025 | Minimed 780g |
| Dexcom, INC. | $321.36 | 2019-2025 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $245.55 | 2021-2024 | Nexlizet, Nexletol |
| Ascensia Diabetes Care US INC. | $236.09 | 2024-2025 | |
| Regeneron Pharmaceuticals, INC. | $215.31 | 2019 | |
| Renalytix Ai, INC. | $188.02 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Sequel Med Tech, LLC | $147.94 | 2025 | Twiist |
| Corcept Therapeutics | $128.25 | 2025 | Korlym |
| Valeritas, INC. | $125.00 | 2019 | |
| Amarin Pharma, INC. | $119.65 | 2022 | |
| Tandem Diabetes Care, INC. | $96.55 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $96.37 | 2022 | |
| Insulet Corporation | $90.11 | 2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $71.93 | 2019-2023 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $62.74 | 2019 | |
| Abbott Laboratories | $59.52 | 2022-2025 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Chavez Velazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.